Back to Results
First PageMeta Content
Neuroendocrinology / Peptide hormones / Growth hormones / Growth hormone treatment / Pediatrics / Growth hormone / Lipodystrophy / HIV-associated lipodystrophy / Pituitary adenoma / Endocrine system / Biology / Medicine


PRIOR AUTHORIZATION POLICY Egrifta™ (tesamorelin injection – EMD Serono) To initiate a Coverage Review, Call[removed]OVERVIEW Egrifta is an analog of human growth hormone-releasing factor (GRF), indicated for
Add to Reading List

Document Date: 2013-10-03 14:58:53


Open Document

File Size: 75,36 KB

Share Result on Facebook
UPDATE